Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,016 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A prospective randomised phase II trial of thalidomide with carboplatin compared with carboplatin alone as a first-line therapy in women with ovarian cancer, with evaluation of potential surrogate markers of angiogenesis.
Muthuramalingam SR, Braybrooke JP, Blann AD, Madhusudan S, Wilner S, Jenkins A, Han C, Kaur K, Perren T, Ganesan TS. Muthuramalingam SR, et al. Among authors: jenkins a. Eur J Gynaecol Oncol. 2011;32(3):253-8. Eur J Gynaecol Oncol. 2011. PMID: 21797111 Clinical Trial.
A phase II feasibility study of carboplatin followed by sequential weekly paclitaxel and gemcitabine as first-line treatment for ovarian cancer.
Harries M, Moss C, Perren T, Gore M, Hall G, Everard M, A'Hern R, Gibbens I, Jenkins A, Shah R, Cole C, Pizzada O, Kaye S. Harries M, et al. Among authors: jenkins a, a hern r. Br J Cancer. 2004 Aug 16;91(4):627-32. doi: 10.1038/sj.bjc.6602000. Br J Cancer. 2004. PMID: 15238984 Free PMC article. Clinical Trial.
Optimized sequence of drug administration and schedule leads to improved dose delivery for gemcitabine and paclitaxel in combination: a phase I trial in patients with recurrent ovarian cancer.
Poole CJ, Perren T, Gawande S, Ridderheim M, Cook J, Jenkins A, Roychowdhury D. Poole CJ, et al. Among authors: jenkins a. Int J Gynecol Cancer. 2006 Mar-Apr;16(2):507-14. doi: 10.1111/j.1525-1438.2006.00466.x. Int J Gynecol Cancer. 2006. PMID: 16681719 Clinical Trial.
A feasibility study of sequential doublet chemotherapy comprising carboplatin-doxorubicin and carboplatin-paclitaxel for advanced endometrial adenocarcinoma and carcinosarcoma.
Ang JE, Shah RN, Everard M, Keyzor C, Coombes I, Jenkins A, Thomas K, A'Hern R, Jones RL, Blake P, Gabra H, Hall G, Gore ME, Kaye SB. Ang JE, et al. Among authors: jenkins a, a hern r. Ann Oncol. 2009 Nov;20(11):1787-93. doi: 10.1093/annonc/mdp193. Epub 2009 Jun 19. Ann Oncol. 2009. PMID: 19542250 Free article. Clinical Trial.
A phase II study of interferon-alpha, interleukin-2 and 5-fluorouracil in advanced renal carcinoma: clinical data and laboratory evidence of protease activation.
Joffe JK, Banks RE, Forbes MA, Hallam S, Jenkins A, Patel PM, Hall GD, Velikova G, Adams J, Crossley A, Johnson PW, Whicher JT, Selby PJ. Joffe JK, et al. Among authors: jenkins a. Br J Urol. 1996 May;77(5):638-49. doi: 10.1046/j.1464-410x.1996.09573.x. Br J Urol. 1996. PMID: 8689103 Clinical Trial.
2,016 results